News|Articles|June 20, 2013
High Potency APIs Video
A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.
Advertisement
A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
3
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
4
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
5